Skip to main content
Programmable Infusion Pumps Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, China, Germany, France - Size and Forecast 2024-2028

Programmable Infusion Pumps Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, China, Germany, France - Size and Forecast 2024-2028

Published: Feb 2024 161 Pages SKU: IRTNTR40731

Market Overview at a Glance

$819.24 Mn
Market Opportunity
8.52%
CAGR
7.84
YoY growth 2023-2024(%)

Programmable Infusion Pumps Market Forecast 2024-2028

The global programmable infusion pumps market size is estimated to grow by USD 819.24 million at a CAGR of 8.52% between 2023 and 2028. 

A slew of new products has been launched in the market, thus providing better options to buyers, which, in turn, helps to stimulate the overall demand for medical equipment in the market. Encouraged by this growth in demand, healthcare equipment manufacturers are seeking opportunities to convert this demand into a continuous cycle of innovation and improvisation by enhancing their products. Thus, all these factors have the potential to accelerate the growth of the global healthcare equipment market, including the market during the forecast period.

What will be the Size of the Market During the Forecast Period?

Programmable Infusion Pumps Market Size

To learn more about this report, Download Report Sample

Segmentation by Type, End-user and Geography Analysis

Type

The market share growth by the large-volume infusion pumps segment will be significant during the forecast period. Large-volume infusion pumps are the market leading in the market, driving significant growth in recent years. These pumps play a key role in healthcare settings, ensuring the correct and regulated delivery of large amounts of fluid, making them indispensable in critical care and intravenous therapy. Key market players such as Baxter International Inc. are driving expansion by developing large-volume infusion pumps with advanced features, enhanced safety standards, and user-friendly interfaces. 

Programmable Infusion Pumps Market Size

Get a glance at the market contribution of various segments Download PDF Sample

The large-volume infusion pumps were the largest and were valued at USD 752.97 million in 2018. The rising frequency of chronic diseases, increased demand for home-based healthcare solutions, and technological breakthroughs that improve the efficiency of large-volume infusion pumps all drive the market scenario. The prevalence of these pumps emphasizes their critical role in providing precise and dependable infusion therapies across a wide range of medical applications. Such factors will continue to drive the demand for large-volume infusion pumps, which, in turn, will drive the growth of the market during the forecast period.

End-user

Hospitals are a key end-user in the market, driving significant growth in the market. The rising prevalence of chronic diseases, an ageing population, and increased demand for effective drug delivery methods all contribute to hospitals' crucial role as end-users in the market. Leading players such as Becton Dickinson and Co., Baxter International Inc., and Fresenius SE and Co. KGaA provide innovative infusion pump technologies to the hospital sector. These devices are prioritized by hospitals for accurate and regulated medicine administration, delivering optimal patient care. Furthermore, the incorporation of smart infusion systems improves workflow efficiency. The shift towards outpatient services and the requirement for infusion therapy in various medical conditions consolidate hospitals as key end-user, fueling the worldwide market continuing growth during the forecast period.

The market is undergoing an unprecedented transition, with a major growth scenario in the home care settings segment as a main end-user. The rising prevalence of chronic diseases, as well as the ageing population's demand for home-based healthcare, are driving this trend. Medtronic and Baxter are developing programmable infusion pumps for home care settings, giving patients more autonomy and comfort. Leading businesses such as Medtronic Plc and B. Braun SE are catering to these end-user sectors by producing innovative programmable infusion pumps that ensure precise drug delivery in a variety of healthcare settings. Collaboration between pump makers and academic institutions drives innovation even further, developing a market situation in which programmable infusion pumps play a critical role in improving patient care across varied healthcare settings. Owing to such factors, the demand for programmable infusion pumps is expected to increase from the other segments, which, in turn, will drive the growth of the market during the forecast period.

Regional Analysis

Programmable Infusion Pumps Market Share by Geography

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 33% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional market trends and analysis, and drivers will shape the market during the forecast period. North America accounted for the largest share of the global programmable infusion pumps market, mainly due to the growing prevalence of chronic diseases, such as diabetes, cancer, and arthritis, among others; the increasing geriatric population; growing technological advances that enable the development of innovative devices; and rising healthcare expenditure. Moreover, the growing awareness among patients regarding the availability of self-administration drug delivery technologies, the increasing number of product approvals, and the growing presence of global and local manufacturers of programmable infusion pumps are fueling the growth of the market in North America.

In addition, the growing demand for premium-priced infusion pump systems to increase patient care quality is likely to drive the market in North America to new heights during the forecast period. The market for programmable infusion pumps in this region is projected to be driven by government measures to cut healthcare expenses in the region by increasing the use of home care equipment. This will increase the need for mobile and disposable infusion pumps in home care settings during the forecast period.

Buy Full Report Now

Key Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Ace medical - The company offers programmable infusion pumps such as Auto Fuser S, Auto Fuser K, and Auto Med Ambulatory Infusion system.

  • Avanos Medical Inc.
  • B.Braun SE
  • Baxter International Inc.
  • Becton Dickinson and Co.
  • BPL MEDICAL TECHNOLOGIES Pvt. Ltd.
  • Canafusion Technologies Inc.
  • Chemyx Inc.
  • Contec Medical Systems Co. Ltd.
  • ERENLER MEDIKAL SAN. TIC. LTD. STI.
  • Flowonix Medical Inc.
  • Fresenius SE and Co. KGaA
  • Guangzhou Beaconn Medical Science Technology Co. Ltd.
  • ICU Medical Inc.
  • IRadimed Corp.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. 

Key Drivers

Growing demand for self-administered drug delivery in home-care settings is notably driving market growth. In certain cases, patients need to receive therapeutic treatment on a regular basis. Certain therapeutic medications can be self-administered as per the recommendation of healthcare professionals. The rise in the number of people with various medical conditions, such as arthritis, diabetes, and cancer, where the timing of the medication is a crucial factor, has increased the demand for self-administered drug delivery systems for use in home-care settings. Self-administration of various therapeutic medications in home-care settings has increased exponentially, owing to the enhanced improvements in the patients health outcomes and the reduced need for them to be admitted to hospitals and clinics to undergo regular treatments.

 Moreover, patient-controlled analgesia pumps are also used in home-care settings. In PCA, a programmable and computerized pump contains a syringe of pain medication as recommended by the healthcare professional. PCA is majorly used by patients who have undergone a surgical procedure. For instance, the TPCA ambulatory patient-controlled syringe pump is one of the PCAs most commonly used by patients who are in need of pain management therapy. This device incorporates a library of dose error reduction software systems, which can be set as per the patient's need for pain management in a home-care setting. Such factors are expected to drive the market growth and trends during the forecast period.

Significant  Trends

The growing number of acquisitions in the market is an emerging trend shaping market development. The manufacturers and developers of programmable infusion pumps are focusing on developing an extensive range of programmable infusion pumps to improve the effectiveness and efficiency of drug and nutrient administration to patients. Programmable infusion pumps are integrated with safety software that helps healthcare providers to minimize the risk of overdose or underdose of medications.

Moreover, many companies operating in the market are focusing on acquisitions to enhance their technological landscape and broaden their product offerings for programmable infusion pumps and thereby strengthening the customer base by fulfilling the unmet needs of patients. Through this inorganic growth strategy, the major vendors present are also establishing themselves in the market during the forecast period.

Major  Challenges

Frequent product recalls of programmable infusion pumps are a significant challenge hindering market growth. The global healthcare equipment industry witnesses frequent product recalls on account of safety or functionality issues. There are instances where healthcare equipment such as medical equipment must be checked, adjusted, or fixed to ensure that it does not fail unexpectedly or violate regulatory guidelines. Medical equipment manufacturers may also recall their devices to inspect and repair them so that they do not cause serious health issues in patients.

In addition, the Food and Drug Administration (FDA) is responsible for updating the Medical Device Recall Database after a company has initiated a correction or removal of its equipment. Thus, such instances cause a major setback to the underlying players financial books and hamper the growth of the global healthcare equipment market, including the market during the forecast period.

Buy Now Full Report

Key Market Customer Landscape

The market forecasting report includes the adoption lifecycle of the market research and growth, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market analysis and report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth and forecasting strategies.

Programmable Infusion Pumps Market Share by Geography

 Customer Landscape

Market Analyst Overview

The market is intricately linked with various healthcare aspects, playing a pivotal role in surgeries and facilitating treatments in diverse settings such as ambulatory care settings. Recognizing the significance of patient safety, especially highlighted in the Institute of Medicine report, the market addresses crucial device design considerations to mitigate medication errors. With a focus on enhancing healthcare systems, the integration of wireless connectivity and features like auto-preprogramming and auto-documentation in smart pumps aims to reduce adverse events and medical injuries associated with intravenous (IV) infusions and adverse drug events (ADEs).

Moreover, the infusion pump market ecosystem involves various stakeholders, including distributors, research & product developers, and end users spanning the specialty infusion pump segment, traditional infusion pump segment, diabetes management segment, analgesia/pain management segment, and specific segments like ambulatory care setting and hospitals. The market adapts to the evolving landscape with a focus on interoperability and addressing patient needs in ASCs (Ambulatory Surgical Centers), influenced by factors such as per capita income and evolving treatment options in healthcare.

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028.

  • Type Outlook
    • Large-volume infusion pumps
    • Small-volume infusion pumps
  • End-user Outlook
    • Hospitals
    • Home care settings
  • Region Outlook
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of World (ROW)
      • Brazil
      • Argentina 
      • Australia 

Programmable Infusion Pumps Market Scope

Report Coverage

Details

Page number

161

Base year

2023

Historic period

 2018-2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 8.52%

Market Growth 2024-2028

USD 819.24 million

Market structure

Fragmented

YoY growth 2023-2024(%)

7.84

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 33%

Key countries

US, Canada, China, Germany, and France

Competitive landscape

 Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

Ace medical, Avanos Medical Inc., B.Braun SE, Baxter International Inc., Becton Dickinson and Co., BPL MEDICAL TECHNOLOGIES Pvt. Ltd., Canafusion Technologies Inc., Chemyx Inc., Contec Medical Systems Co. Ltd., ERENLER MEDIKAL SAN. TIC. LTD. STI., Flowonix Medical Inc., Fresenius SE and Co. KGaA, Guangzhou Beaconn Medical Science Technology Co. Ltd., ICU Medical Inc., IRadimed Corp., Johnson and Johnson, Medtronic Plc, Moog Inc., Terumo Corp., and Ypsomed Holding AG

Market dynamics

Parent market growth analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period. 

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Programmable Infusion Pumps Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the between 2024 and 2028
  • Precise estimation of the size and its contribution n of the market in focus to the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Companies landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on companies position and classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

Table of Contents not available.

Research Methodology

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

Interested in this report?

Get your sample now to see our research methodology and insights!

Download Now

Frequently Asked Questions

Programmable Infusion Pumps market growth will increase by $ 819.24 mn during 2024-2028.

The Programmable Infusion Pumps market is expected to grow at a CAGR of 8.52% during 2024-2028.

Programmable Infusion Pumps market is segmented by Type( Large-volume infusion pumps, Small-volume infusion pumps) End-user( Hospitals, Home care settings, Asia, Rest of World (ROW))

Ace medical, Avanos Medical Inc., B.Braun SE, Baxter International Inc., Becton Dickinson and Co., BPL MEDICAL TECHNOLOGIES Pvt. Ltd., Canafusion Technologies Inc., Chemyx Inc., Contec Medical Systems Co. Ltd., ERENLER MEDIKAL SAN. TIC. LTD. STI., Flowonix Medical Inc., Fresenius SE and Co. KGaA, Guangzhou Beaconn Medical Science Technology Co. Ltd., ICU Medical Inc., IRadimed Corp., Johnson and Johnson, Medtronic Plc, Moog Inc., Terumo Corp., Ypsomed Holding AG are a few of the key vendors in the Programmable Infusion Pumps market.

North America will register the highest growth rate of 33% among the other regions. Therefore, the Programmable Infusion Pumps market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

US, Canada, China, Germany, France

  • Increasing incidence of chronic diseasesThe incidence and prevalence of chronic diseases is the driving factor this market.
  • such as diabetes is the driving factor this market.
  • arthritis is the driving factor this market.
  • cancer is the driving factor this market.
  • and obesity is the driving factor this market.
  • among others is the driving factor this market.
  • have increased among all age groups of people across the globe. These chronic diseases need long-term treatment with proper therapeutic medications recommended by healthcare professionals. Inactive lifestyles is the driving factor this market.
  • physiological changes is the driving factor this market.
  • and genetic factors play a major role in the growing burden of chronic diseases among people worldwide. Diabetes is one of the major chronic diseases prevalent worldwide. Diabetes can lead to severe complications is the driving factor this market.
  • such as heart attack is the driving factor this market.
  • hypertension is the driving factor this market.
  • stroke is the driving factor this market.
  • and kidney failure is the driving factor this market.
  • among others. Diabetes and other medical complications associated with the disease can be controlled and avoided with proper treatment. Patients suffering from diabetes need long-term treatment to maintain their health and reduce the chances of dying due to diabetes. Programmable infusion pumps are majorly used by healthcare professionals to provide proper medication to patients. In order to eliminate frequent visits to the hospitals for the administration of insulin by doctors is the driving factor this market.
  • people with diabetes can use programmable infusions in their homes. Healthcare professionals recommend that diabetes patients use programmable infusion pumps for self-administering insulin at home is the driving factor this market.
  • as this eliminates the risk of an overdose or underdose is the driving factor this market.
  • unlike in other drug delivery technologies. In addition is the driving factor this market.
  • the incidence of arthritis is the driving factor this market.
  • one of the most common chronic diseases is the driving factor this market.
  • which is most prevalent in the geriatric population is the driving factor this market.
  • has increased significantly across the globe. It is expected to increase in the coming years is the driving factor this market.
  • primarily due to the sedentary lifestyles of people worldwide. Cancer cases are also increasing significantly across the globe and are contributing to the mortality rate worldwide. For instance is the driving factor this market.
  • it is anticipated that there will be approximately 600 is the driving factor this market.
  • 000 cancer deaths and 1 is the driving factor this market.
  • 900 is the driving factor this market.
  • 000 new cancer cases in the US in 2022. Breast cancer is the driving factor this market.
  • prostate cancer is the driving factor this market.
  • and cervical cancer are the most common types of cancer affecting people in the US. Patients suffering from cancer need to take analgesics for pain management as well as chemotherapy agents for treatment. Programmable infusion pumps help in the administration of analgesics and chemotherapy agents in a hospital is the driving factor this market.
  • clinic is the driving factor this market.
  • or home-care setting. The unique features that are integrated with programmable infusion pumps is the driving factor this market.
  • such as drug libraries and dose error correction software is the driving factor this market.
  • aid in providing effective treatment to cancer patients. Therefore is the driving factor this market.
  • the incidence and prevalence of chronic diseases have increased the demand for programmable infusion pumps and will is the driving factor this market.
  • therefore is the driving factor this market.
  • propel the growth of the global programmable infusion pumps market during the forecast period. is the driving factor this market.

The Programmable Infusion Pumps market vendors should focus on grabbing business opportunities from the Large-volume infusion pumps segment as it accounted for the largest market share in the base year.